Doc Akers-White Faces Secret Federal Ruling: What Happened?
Published Date: 12/4/2025
Notice
Summary
Dr. Latania Akers-White from Virginia lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing to challenge this, so the DEA officially revoked her registration as of June 30, 2025. This means she can’t prescribe or manage controlled drugs anymore, affecting her medical practice and patients.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Dr. Akers-White
The DEA revoked Latania Akers-White, M.D.'s Certificate of Registration No. FA2343630 and denied any pending applications to renew, modify, or add registrations in Virginia. The registration revocation order is effective January 5, 2026; her DEA registration had expired on June 30, 2025 and her Virginia medical license was suspended on or about July 11, 2024.
DEA Authority When State License Suspended
Under 21 U.S.C. 824(a)(3) and related provisions, the DEA may suspend or revoke a practitioner's registration when the practitioner's State license or registration has been suspended or revoked so that the practitioner is no longer authorized to handle controlled substances in that State. The agency states that a practitioner must have state authority to dispense controlled substances in the State where they practice to be eligible to maintain a DEA registration.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical
Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.
2026-06521 — Importer of Controlled Substances Application: Lipomed/LGC Standards
Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
2026-05618 — Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
Previous / Next Documents
Previous: 2025-21884 — Agency Information Collection Activities; Submission of Proposed Information Collection; Online Training Request Form for OMB Review
The Access Board is asking for approval to start a new online form that lets people and local governments easily request training. This change makes it simpler to get help and doesn’t cost anyone extra. You can share your thoughts on this plan until January 5, 2026.
Next: 2025-21886 — Endangered and Threatened Species; Issuance of Enhancement of Survival and Incidental Take Permits for Safe Harbor Agreements, Candidate Conservation Agreements, Conservation Plans, and Recovery Activities; January 1, 2024, Through December 31, 2024
The U.S. Fish and Wildlife Service is sharing a list of permits issued in 2024 that allow certain activities affecting endangered and threatened species. These permits help people and groups safely work on conservation projects, recovery efforts, and habitat plans without breaking the law. This update keeps everyone informed about who’s involved, what’s allowed, and when these permits apply throughout the year.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in